Mirati Therapeutics
MRTX
#3044
Rank
S$5.51 B
Marketcap
$78.56
Share price
0.00%
Change (1 day)
48.30%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : S$1.30 Billion

According to Mirati Therapeutics's latest financial reports the company has S$1.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$1.45 B-27.93%
2021-12-31S$2.01 B9.63%
2020-12-31S$1.83 B228.65%
2019-12-31S$0.55 B83.85%
2018-12-31S$0.30 B50.87%
2017-12-31S$0.20 B145.7%
2016-12-31S$82.11 M-52.55%
2015-12-31S$0.17 B346.9%
2014-12-31S$38.71 M-50.76%
2013-12-31S$78.64 M73.88%
2012-12-31S$45.22 M23.26%
2011-12-31S$36.69 M287.04%
2010-12-31S$9.48 M-59.5%
2009-12-31S$23.4 M-48.4%
2008-12-31S$45.36 M-48.59%
2007-12-31S$88.25 M1.98%
2006-12-31S$86.53 M130.17%
2005-12-31S$37.59 M-33.11%
2004-12-31S$56.2 M39.22%
2003-12-31S$40.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.51 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.17 M-99.99% Bahamas